Generate a tailored SOP for Dr. Richard Timms. Improve your application with a focused, well-structured draft.
Richard Timms leads a research team at the Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), focusing on cellular immune responses, immune regulation, and host defenses. His academic journey began with a PhD under Professor Paul Lehner, where he developed genetic screens utilizing haploid human cells to study viral E3 ubiquitin ligases. As a Sir Henry Wellcome Postdoctoral Fellow with Professor Steve Elledge at Harvard Medical School, he explored novel degradative pathways via Cullin-RING E3 ligases. His recent work utilizes genetic tools and CRISPR/Cas9 technology to identify novel genes involved in chromatin regulation, contributing significantly to the understanding of protein stability and virally induced processes in human cells. His work has implications in epigenetic silencing and immunopeptidomics, showcasing his commitment to advancements in therapeutic targets and cellular process understanding.
Cambridge Institute of Therapeutic Immunology & Infectious Disease • Cambridge, UK
Lead a research group focused on cellular immune responses and genetic regulation in human cells.
Standard postgraduate requirements for Department of Politics and International Studies (POLIS) and related humanities departments.